Vor Biopharma (VOR) Shares Outstanding (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Shares Outstanding data on file, last reported at $54.2 million in Q1 2026.

• Quarterly Shares Outstanding rose 768.0% year-over-year to $54.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.2 million (up 768.0% YoY) and the FY2025 annual result came in at $38.7 million, up 520.64% from the prior year.
• Shares Outstanding rose to $54.2 million in Q1 2026 per VOR's latest filing, from $38.7 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $67.8 million in Q3 2023 and bottomed at $3.4 million in Q4 2023.
• The 5-year median for Shares Outstanding is $37.3 million (2022), against an average of $30.3 million.
• The widest annual swing landed in 2024, when Shares Outstanding tumbled 94.94%; it then jumped 768.0% in 2026.
• Tracing VOR's Shares Outstanding over 5 years: stood at $66.0 million in 2022, then plunged by 94.86% to $3.4 million in 2023, then soared by 83.76% to $6.2 million in 2024, then soared by 520.64% to $38.7 million in 2025, then soared by 39.94% to $54.2 million in 2026.
• Per Business Quant, the three latest VOR Shares Outstanding figures stand at $54.2 million (Q1 2026), $38.7 million (Q4 2025), and $9.0 million (Q3 2025).

Peer Comparison